NIH-funded research R01 grant

Lung ultrasound with AI to detect tuberculosis in adults in low-resource countries

Official title: Lung Ultrasound and Artificial Intelligence Technology for the Diagnosis of TB in LMICs

Funded at Johns Hopkins University · NIH-11506692 · Data updated 2026-11-12

This project uses quick lung ultrasound scans plus artificial intelligence to help find pulmonary tuberculosis in adults in low- and middle-income countries.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startFebruary 15, 2024
Project endJanuary 31, 2029
Funding year2026
Award (this year)$75,380
NIH project number3R01HL168261-03S2
Project IDNIH-11506692 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21 years and older) with symptoms suggestive of pulmonary TB who present to participating clinics in low- and middle-income countries are the intended candidates.

Less likely to help

People without lung symptoms, children, or those with extrapulmonary or latent TB are unlikely to benefit directly from this lung-ultrasound approach.

What this research studies

If you visit a participating clinic, a health worker would do a brief, portable lung ultrasound at the point of care. An AI program will analyze the ultrasound images in real time to flag findings that suggest pulmonary TB and help decide who needs further testing like sputum/Xpert. The team will train local providers on scanning and refine procedures so the approach works well in low-resource settings. The aim is to make a fast, low-cost way to triage people with TB symptoms so they get the right tests and treatment sooner.

Why it matters

Potential benefit: If successful, this could speed up TB diagnosis and help people start treatment sooner, especially where lab testing is limited.

How similar studies have gone: Preliminary data and small studies suggest lung ultrasound can be highly sensitive for pulmonary TB, but large, rigorous trials of AI-driven LUS for TB are still limited.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Gilman, Robert H — Johns Hopkins University
  • Study coordinator: Gilman, Robert H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.